Member Directory

American Regent (formerly Pharmaforce) is a leader in the development, manufacturing and sales of generic and branded IV products. With a history of 50 years in generic specialty injectables, American Regent has sales approaching one billion dollars. American Regent strives for continuous improvement to bring to market high quality innovative medications to meet unmet medical needs, and produces high quality accessible generic medications covering a wide array of therapeutic areas. American Regent is a member of the Daiichi Sankyo Group; and is headquartered in Shirley, NY. The company is capable of manufacturing a full range of pharmaceutical products including injectables, ophthalmics, otics, nasals, simple solutions and suspensions, oncolytics, highly potent compounds, biologics and large molecules. Development of drug products covers a wide therapeutic range including vasodilators, anti-arrhythmic agents, CNS agents, anti-infectives, immuno-suppressants, antifungals, beta-blockers and antivirals. Developmental capabilities also include active pharmaceutical ingredient qualification, analytical methods development and validation, product stability storage and monitoring, analytical testing and drug product dossier development and submission.